All In Biotech

Drug Trial Radar · NCT07349381

A Food-Effect Study of CX11 in Healthy Participants

An Open-label, Randomized, Multiple-dose, Two-cycle, Two-way Crossover Phase 1 Study to Evaluate the Effect of Food on the Pharmacokinetics of CX11 Tablets in Healthy Participants

Last checked: Nov 19, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

32

Actual

Start

Mar 4, 2026

Primary completion

Jun 30, 2026

Study completion Aug 30, 2026

Sponsor

Lead sponsor
Vincentage Pharma Co., LtdIndustry
Sponsor type
Industry
Collaborators
Corxel Pharmaceuticals
First posted
Jan 16, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Basic science
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study is to evaluate the food effect (FE) on the PK of 200 mg CX11 in healthy participants

Conditions

  • Obesity & Overweight
  • Type 2 Diabetes

Interventions

  • CX11 (VCT220)Drug

    CX11 (VCT220) administered orally to participants who are in fasted/fed state in the first 6 consecutive days, and in fed/fasted state on the 7th day

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Area Under the Concentration-time curve from 0 to 24 hour (AUC0-24) of CX11 (VCT220)Time frame: Predose at Day1 up to 35 days postdose
  2. Maximum Observed Concentration (Cmax) of CX11 (VCT220)Time frame: Predose at Day1 up to 35 days postdose
  3. Time to Maximum Observed Concentration (Tmax) of CX11 (VCT220)Time frame: Predose at Day 1 up to 35 days postdose

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Shanghai Xuhui Central Hospital

    Shanghai, Shanghai Municipality, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.